Gustavo de Oliveira Luz

Gustavo de Oliveira Luz

Auto-generated profile, based on publicly available information

Gustavo de Oliveira Luz

Hospital das Clínicas da Universidade de São Paulo, Unidade de Endoscopia Gastrointestinal, São Paulo, SP, Brasil

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 November 2020 in Clinical Endoscopy
Verified
Journal Article
Open access
PDF file
EJEpifanio Silvino Do Monte Junior
Epifanio Silvino Do Monte Junior
MSMarcos Eduardo Lera dos Santos
Marcos Eduardo Lera dos Santos
IRIgor Braga Ribeiro
Igor Braga Ribeiro
GLGustavo De Oliveira Luz
Gustavo De Oliveira Luz
EBElisa Ryoka Baba
Elisa Ryoka Baba
EMEduardo Guimarães Hourneaux de Moura
Eduardo Guimarães Hourneaux de Moura
The novel coronavirus disease (COVID-19) quickly spread to all continents. However, data regarding all the signs and symptoms of COVID-19 are insufficient. Patients with COVID-19 might present higher susceptibility to fungal coinfections. Mucormycosis is a rare and often life-threatening fungal disease characterized by vascular invasion by hyphae, resulting in thrombosis and necrosis. This is the first case report of mucormycosis in a COVID-19 patient. An 86-year-old male patient was admitted to the emergency room with acute diarrhea, cough, dyspnea, and fever from 5 days prior. Blood tests revealed a hemoglobin level of 14.3 mg/dL. Five days following the admission, the patient presented with melena and a hemoglobin level of 5.6 mg/dL. A transfusion of three units of red blood cells was required. Esophagogastroduodenoscopy (EGD) revealed two giant gastric ulcers with necrotic debris and a deep hemorrhagic base without active bleeding. Furthermore, biopsies confirmed mucormycosis. Despite intensive care, the patient died 36 hours after the EGD.

1 June 2019 in Arquivos de Gastroenterologia
Verified
Journal Article
Open access
PDF file
CCCláudia Alves Couto
Cláudia Alves Couto
DTDebora Raquel Benedita Terrabuio
Debora Raquel Benedita Terrabuio
ECEduardo Luiz Rachid Cançado
Eduardo Luiz Rachid Cançado
GPGilda Porta
Gilda Porta
CLCynthia Levy
Cynthia Levy
TSTiago Sevá-Pereira
Tiago Sevá-Pereira
New data concerning the management of autoimmune liver diseases have emerged since the last single-topic meeting sponsored by the Brazilian Society of Hepatology to draw recommendations about the diagnosis and treatment of autoimmune hepatitis (AIH), primary biliary cholangitis (PBC), primary sclerosing cholangitis (PSC), overlap syndromes of AIH, PBC and PSC and specific complications and topics concerning AIH and cholestatic liver diseases. This manuscript updates those previous recommendations according to the best evidence available in the literature up to now. The same panel of experts that took part in the first consensus document reviewed all recommendations, which were subsequently scrutinized by all members of the Brazilian Society of Hepatology using a web-based approach. The new recommendations are presented herein.

1 January 2024 in Arquivos de Gastroenterologia
Verified
Journal Article
Open access
PDF file
RPRicardo Rangel de Paula Pessoa
Ricardo Rangel de Paula Pessoa
ABAlexandre Moraes Bestetti
Alexandre Moraes Bestetti
VOVictor Lira de Oliveira
Victor Lira de Oliveira
WAWladimir Campos de Araujo
Wladimir Campos de Araujo
SGSimone Guaraldi
Simone Guaraldi
GLGustavo de Oliveira Luz
Gustavo de Oliveira Luz
Background: In the past decades, endoscopic ultrasound has developed from a diagnostic tool to a platform for many therapeutic interventions. Various technological advancements have emerged since the last Brazilian Consensus, demanding a review and update of the recommendations based on the best scientific evidence. Methods: A group of 32 renowned echoendoscopists selected eight relevant topics to be discussed to generate clinical questions. After that, a literature review was conducted to answer these questions based on the most updated evidence. Results: Thirty-three statements were formulated and voted on by the experts to reach a consensus. The Oxford System was used to grade the level of evidence. Conclusion: There is moderate evidence to support that the needle shape, gauge, or aspiration technique does not influence the yield of endoscopic ultrasound (EUS)-guided tissue sampling of pancreatic solid lesions. There is moderate evidence to support using EUS-TTNB of the cyst wall to differentiate between mucinous and non-mucinous cystic neoplasms. There is little evidence to support the EUS-guided treatment of gastric varices. There is a high level of evidence to support that EUS-guided biliary drainage and ERCP present similar outcomes in patients with distal malignant biliary obstruction. There is a high level of evidence for using EUS to diagnose neoplastic pancreatic cysts and detect necrosis before indicating drainage. There is moderate evidence to support EUS-GE over duodenal stent for malignant gastric outlet obstruction in patients with a life expectancy higher than 2 months. There is a high level of evidence to support the use of RFA in treating both functioning and non-functioning types of NET.

20 November 2026 in Techniques and Innovations in Gastrointestinal Endoscopy
Verified
Journal Article
Closed access
AMAmanda Ribas Mendes
Amanda Ribas Mendes
GLGustavo de Oliveira Luz
Gustavo de Oliveira Luz
EMEduardo Turiani Hourneaux de Moura
Eduardo Turiani Hourneaux de Moura
MSMarcos Eduardo Lera dos Santos
Marcos Eduardo Lera dos Santos
MWMarcella de Albuquerque Wanderley
Marcella de Albuquerque Wanderley
EMEduardo Guimarães Hourneaux de Moura
Eduardo Guimarães Hourneaux de Moura

9 January 2026
Verified
Journal Article
Open access
TFTomazo Antônio Prince Franzini
Tomazo Antônio Prince Franzini
BMBruno da Costa Martins
Bruno da Costa Martins
ABAlexandre Moraes Bestetti
Alexandre Moraes Bestetti
CACarlos Henrique Barros Amaral
Carlos Henrique Barros Amaral
CSCláudio Rogério Solak
Cláudio Rogério Solak
FMFauze Maluf-Filho
Fauze Maluf-Filho
Despite the widespread adoption of single-operator cholangiopancreatoscopy for the management of biliary and pancreatic diseases, this method was recently introduced in Brazil. This study aimed to develop a Brazilian consensus for the diagnostic and therapeutic use of single-operator cholangiopancreatoscopy for the management of pancreatobiliary diseases. A working group from the Brazilian Society of Digestive Endoscopy (SOBED) specialists, using a Delphi methodology, formulated statements across six topics: indeterminate biliary strictures, complex biliary stones, primary sclerosing cholangitis, peroral pancreatoscopy, post-liver transplantation, and antibiotic prophylaxis. Eighteen experts evaluated these statements using an anonymous electronic voting system. Consensus was defined as ≥80% agreement. Eighteen statements were formulated and voted on by a panel of experts to reach a consensus. The panel consisted of 18 endoscopy specialists from various regions of Brazil, with an average of 20.4 years of experience. Consensus was achieved on all statements in the first round. These recommendations establish the role of cholangiopancreatoscopy in diagnostic and therapeutic for indeterminate biliary strictures, complex biliary stones, primary sclerosing cholangitis, peroral pancreatoscopy, post-liver transplantation, and antibiotic prophylaxis, providing a background for its standardized use in Brazil.